Centro de Investigación del Medicamento (CIM)

Developed by: Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau)



The CIM (has conducted a series of activities focused on Human Drug Effects, from both pharmacological and therapeutic perspectives. Among these special attention has been paid to the initial stage assessment of drug effect in humans, i.e., Phase I Clinical Trials in Healthy Volunteers.

Equipment / Know-How

More than 200 clinical trials have been performed involving a wide range of pharmacological agents. Most of this activity has been accomplished in collaboration with the Pharmaceutical Industry including tolerability, pharmacokinetic, pharmacodynamic and bioequivalence studies. 

Contact Details
Responsible: Rosa Maria Antonijoan
E-mail: rantonijoana@santpau.cat